Arrowstreet Capital, Limited Partnership Agenus Inc Transaction History

Arrowstreet Capital, Limited Partnership

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$2.35 - $3.47 $1.03 Million - $1.51 Million	-436,525 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$2.92 - $5.74 $1.27 Million - $2.51 Million	436,525 New	436,525 $1.41 Million
Q1 2021 May 14, 2021	SELL	$2.69 - $5.25 $78,488 - $153,184	-29,178 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$3.17 - $4.49 $92,494 - $131,009	29,178 New	29,178 $93,000
Q3 2020 Nov 12, 2020	SELL	$2.98 - $5.2 $228,542 - $398,798	-76,692 Closed	0 $0
Q2 2020 Aug 12, 2020	BUY	$2.29 - $4.24 $10,181 - $18,851	4,446 Added 6.15%	76,692 $301,000
Q1 2020 May 15, 2020	SELL	$1.92 - $4.39 $461,016 - $1.05 Million	-240,113 Reduced 76.87%	72,246 $177,000
Q4 2019 Feb 13, 2020	BUY	$2.41 - $4.4 $752,785 - $1.37 Million	312,359 New	312,359 $1.27 Million

2.07M

Ticker AGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 283,163,008
Market Cap $4.73B
Description
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...

Get notified when there are updates to the investment portfolio of Arrowstreet Capital, Limited Partnership, based on Form 13F filings with the SEC.

Stay updated on Arrowstreet Capital, Limited Partnership with notifications on news.